VivoSeq
Other

Enoxaparin

0

Pipeline Programs↗

0

Active Trials↗

4

Companies Involved↗

Enoxaparin is an early-stage landscape with 0 programs across 4 companies. The most active players are Rovi Pharmaceuticals Laboratories, Berlin-Chemie AG Menarini Group, Boehringer Ingelheim.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

88/100

Attrition Rate

11/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

R

Rovi Pharmaceuticals Laboratories

0 programs

PreclinicalB

Berlin-Chemie AG Menarini Group

0 programs

PreclinicalBoehringer Ingelheim logo

Boehringer Ingelheim

0 programs

PreclinicalA

AMAG Pharmaceuticals, Inc.

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

18

clinical trials

Completed15 · 83%
Terminated2 · 11%
Unknown status1 · 6%

Clinical Trials

Trial Activity

18 trials

Safety Evaluation of Use Sodic Enoxaparin
Completed·—·Phase 3·NCT00673426·60 enrolled
Bioequivalence Study of a Generic Enoxaparin Sodium to Clexane® After Single Subcutaneous Dose in Healthy Human Subjects
Completed·VVenus Remedies Limited·Phase 1·NCT05265676·24 enrolled
Enoxaparin Versus Unfractionated Heparin in PCI
Completed·TTriemli Hospital·Phase 4·NCT00439855·2,100 enrolled
Study of Pharmacodynamic Equivalence of Enoxaparin Rovi to Clexane®, in Healthy Volunteers
Completed·RRovi Pharmaceuticals Laboratories·Phase 1·NCT03363477·46 enrolled
Heparin or Enoxaparin in Patients With Cancer
Completed·NNorthwestern University·N/A·NCT00004875·6 enrolled
Study to Evaluate Weight-based Enoxaparin Dosing in Obese Medical Patients at Risk for DVT
Completed·UUniversity of Utah·Phase 4·NCT00585182·28 enrolled
Thrombelastography Based Dosing of Enoxaparin
Completed·OOregon Health and Science University·N/A·NCT00990236·185 enrolled
Bioavailability Study of Enoxaparin Sodium Chemi and Clexane s.c.
Completed·—·Phase 1·NCT02232802·47 enrolled
Tirofiban and Enoxaparin in High Risk Coronary Intervention
Completed·—·Phase 4·NCT00790387·60 enrolled
Weight-Based Enoxaparin Dosing and Real-Time Dose Adjustment in Orthopaedic Trauma
Completed·UUniversity of Utah·Phase 2·NCT03339349·80 enrolled
Efficacy of Bemiparin Versus Enoxaparin in the Treatment of DVT
Completed·BBerlin-Chemie AG Menarini Group·Phase 3·NCT01880216·312 enrolled
Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to Enoxaparin
Completed·AAvexima Diol LLC·Phase 3·NCT07124819·215 enrolled
Relative Bioavailability and Pharmacodynamics of Dabigatran With Enoxaparin in Healthy Male and Female Volunteers
Completed·Boehringer Ingelheim logoBoehringer Ingelheim·Phase 1·NCT02171559·29 enrolled
PK and PD of Single, Escalating Doses of PER977 Following Enoxaparin
Completed·AAMAG Pharmaceuticals, Inc.·Phase 1/2·NCT02206100·40 enrolled
Pharmacodynamic Equivalence of Ovine Enoxaparin to Lovenox®
Completed·IIndonesia University·Phase 1/2·NCT04402762·20 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)